Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide

被引:56
作者
Vila, J
Nugier, F
Bargues, G
Vallet, T
Peyramond, D
HamediSangsari, F
Seigneurin, JM
机构
[1] CHU GRENOBLE,F-38043 GRENOBLE,FRANCE
[2] UNIV GRENOBLE 1,VIROL LAB,GRENOBLE,FRANCE
[3] HOP CROIX ROUSSE,SERV MALAD INFECT,F-69317 LYON,FRANCE
关键词
D O I
10.1016/S0140-6736(97)24035-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:635 / 636
页数:2
相关论文
共 4 条
[1]   HYDROXYUREA AS AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 REPLICATION [J].
LORI, F ;
MALYKH, A ;
CARA, A ;
SUN, D ;
WEINSTEIN, JN ;
LISZIEWICZ, J ;
GALLO, RC .
SCIENCE, 1994, 266 (5186) :801-805
[2]   SYNERGISTIC ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EFFECT OF HYDROXAMATE COMPOUNDS WITH 2',3'-DIDEOXYINOSINE IN INFECTED RESTING HUMAN-LYMPHOCYTES [J].
MALLEY, SD ;
GRANGE, JM ;
HAMEDISANGSARI, F ;
VILA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11017-11021
[3]   Decay characteristics of HIV-1-infected compartments during combination therapy [J].
Perelson, AS ;
Essunger, P ;
Cao, YZ ;
Vesanen, M ;
Hurley, A ;
Saksela, K ;
Markowitz, M ;
Ho, DD .
NATURE, 1997, 387 (6629) :188-191
[4]   1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection [J].
Vila, J ;
Biron, F ;
Nugier, F ;
Vallet, T ;
Peyramond, D .
LANCET, 1996, 348 (9021) :203-204